GALE News 2.28 04/25/2014 05:33:01 Galena Biopharma (GALE)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Galena Biopharma (GALE) 2.28 $GALE

Galena Biopharma Research Pioneer Presented With 2014 Award for Excellence in Technology Transfer
GlobeNewswire - Thu Apr 24, 6:05AM CDT
Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced that the 2014 Award for Excellence in Technology Transfer was granted to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) and the Uniformed Services University of the Health Sciences (USU). The award was presented by the Federal Laboratory Consortium for Technology Transfer for work by George Peoples, M.D., chief of surgical oncology at the San Antonio Military Medical Center, and his colleagues, for the licensing of NeuVax(TM) (nelipepimut-S), a breast cancer vaccine to reduce breast cancer recurrence.

GALENA BIOPHARMA, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against GALENA BIOPHARMA, INC. and Its Board and a Lead Plaintiff Deadline of May 5, 2014 -- GALE
GlobeNewswire - Wed Apr 23, 6:16PM CDT
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Oregon on behalf of holders of Galena Biopharma, Inc. ("Galena" or the "Company" (Nasdaq:GALE) securities between November 6, 2013 and February 14, 2014.

Top Gainers at a Glance -- Research on Trina Solar, Yingli Green Energy Holding, Galena Biopharma, and Conn's
PR Newswire - Wed Apr 23, 10:43AM CDT
The US markets saw a positive sentiment on Tuesday, April 22, 2014, with the NASDAQ Composite closing at 4,161.46, up 0.97%, the Dow Jones Industrial Average ending the session at 16,514.37, up 0.40%, and the S&P 500 gained 0.41%, to finish the trading session at 1,879.55. The gains were broad based as eight out of ten sectors ended the session in positive. A number of stocks saw large movements, including Trina Solar Ltd (NYSE: TSL), Yingli Green Energy Holding Co. Ltd (NYSE: YGE), Galena Biopharma Inc. (NASDAQ: GALE) and Conn's Inc. (NASDAQ: CONN). Free technical research on TSL, YGE, GALE and CONN can be downloaded upon signing up at:

EQUITY ALERT: Rosen Law Firm Reminds Galena Biopharma, Inc. Investors of Important May 5, 2014 Class Action Deadline -- GALE
GlobeNewswire - Tue Apr 22, 4:07PM CDT
The Rosen Law Firm, P.A. today reminds all purchasers of the common stock of Galena Biopharma, Inc. (Nasdaq:GALE) between November 6, 2013 and February 14, 2014, inclusive of the important May 5, 2014 lead plaintiff deadline in the class action filed by the firm.

INVESTOR ALERT: Law Offices of Howard G. Smith Announces an Expanded Class Period in the Shareholder Lawsuit against Galena Biopharma, Inc.
Business Wire - Tue Apr 22, 9:32AM CDT
Law Offices of Howard G. Smith announces that the class action lawsuit against Galena Biopharma, Inc. ("Galena" or the "Company" (NASDAQ:GALE) filed in the United States District Court for the District of Oregon has been expanded to include all purchasers of Galena common stock between May 9, 2013 and March 17, 2014, inclusive (the "Class Period" .

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 from Investment in Galena Biopharma, Inc. to Contact Brower Piven Before the May 5, 2014 Lead Plaintiff Deadline (GALE)
GlobeNewswire - Mon Apr 21, 5:20PM CDT
Brower Piven, A Professional Corporation announces that a class action lawsuit has been commenced in the United States District Court for the District of Oregon on behalf of purchasers of Galena Biopharma, Inc. ("Galena" or the "Company" (Nasdaq:GALE) common stock during the period between November 6, 2013 and February 14, 2014, inclusive (the "Class Period" .

U.S. District Court Judge Nixes Banning of Zogenix's Painkiller in Massachusetts
ACCESSWIRE - Mon Apr 21, 9:42AM CDT
A U.S. District Court judge stopped Massachusetts from banning the sale of Zogenix Inc.'s (NASDAQ: ZGNX) prescription painkiller Zohydro, saying that the decision was based on the principle that federal law superseded the state's action.

Hagens Berman: Galena Biopharma Investigation Proceeds in Light of May 5, 2014 Lead Plaintiff Deadline in Securities Fraud Class Actions
PR Newswire - Wed Apr 16, 6:56PM CDT
Hagens Berman Sobol Shapiro LLP an investor-rights law firm with offices in San Francisco has intensified its investigation on behalf of Galena Biopharma, Inc. (NASDAQ: GALE) ("Galena" or "the Company" in light of the May 5, 2014 deadline to file for lead plaintiff in the securities fraud cases against the company. Investors who purchased Galena stock between May 9, 2013 and March 17, 2014 (the "Class Period" can contact Hagens Berman Partner Reed Kathrein, who is leading the firm's investigation, by calling 510-725-3000, emailing Galena@hbsslaw.com or visiting http://hb-securities.com/investigations/Galena.

Valuation Doesn't Equal Share Price (and That Goes Double for Biotech)
Brian Orelli, The Motley Fool - Motley Fool - Mon Apr 14, 6:52PM CDT
Most investors realize that share price is meaningless when comparing companies. A company at $50 per share might actually be worth more than a company at $100 per share because a company's value is determined by the number of outstanding shares in...

Lieff Cabraser Reminds Galena Biopharma, Inc. Investors of Upcoming Deadline in Class Action Litigation - GALE
Business Wire - Fri Apr 11, 5:28PM CDT
Lieff Cabraser Heimann & Bernstein, LLP reminds investors of the May 5, 2014 deadline to move for appointment as lead plaintiff in the securities class litigation brought on behalf of those who purchased or otherwise acquired the securities of Galena Biopharma, Inc. ("Galena" or the "Company" (Nasdaq:GALE) between May 9, 2013 and March 17, 2014, inclusive (the "Class Period" .

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Galena Biopharma, Inc. and Certain Officers - GALE
PR Newswire - Fri Apr 11, 3:14PM CDT
Pomerantz LLP has filed a class action lawsuit against Galena Biopharma, Inc. ("Galena" or the "Company" (NASDAQ: GALE) and certain of its officers. The class action, filed in United States District Court, District of Oregon, and docketed under 3:14-cv-00410-HZ, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired Galena securities between March 12, 2013 and February 11, 2014, both dates inclusive (the "Class Period" . This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws pursuant to Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder.

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 from Investment in Galena Biopharma, Inc. to Contact Brower Piven Before the May 5, 2014 Lead Plaintiff Deadline
Business Wire - Wed Apr 09, 4:14PM CDT
Brower Piven, A Professional Corporation announces that a class action lawsuit has been commenced in the United States District Court for the District of Oregon on behalf of purchasers of Galena Biopharma, Inc. ("Galena" or the "Company" (Nasdaq: GALE) common stock during the period between November 6, 2013 and February 14, 2014, inclusive (the "Class Period" .

Financial Results Schedules, Approvals, Appointments, Product Launches, and Stock Movements - Analyst Notes on Allergan, Accuray, Cerus, Galena Biopharma, and ZELTIQ Aesthetic
PR Newswire - Wed Apr 09, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Allergan Inc. (NYSE: AGN), Accuray Incorporated (NASDAQ: ARAY), Cerus Corporation (NASDAQ: CERS), Galena Biopharma, Inc. (NASDAQ: GALE), and ZELTIQ Aesthetics, Inc. (NASDAQ: ZLTQ). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

Hagens Berman Notifies Investors of Extended Class Period and May 5, 2014 Lead Plaintiff Deadline in Galena Biopharma, Inc. Securities Fraud Class Actions
PR Newswire - Mon Apr 07, 4:23PM CDT
Hagens Berman Sobol Shapiro LLP reminds investors of the May 5, 2014 deadline to file for lead plaintiff in a securities fraud case against Galena Biopharma, Inc. (NASDAQ: GALE) ("Galena" or "the Company" . The Class Period has been extended to cover investors who bought stock between May 9, 2013 and March 17, 2014 (the "Class Period" . Investors who purchased Galena securities during the Class Period may contact Hagens Berman Partner Reed Kathrein, who is leading the firm's investigation, by calling 510-725-3000, emailing Galena@hbsslaw.com or visiting http://hb-securities.com/investigations/Galena.

INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Galena Biopharma, Inc.
Business Wire - Thu Apr 03, 12:03PM CDT
Glancy Binkow & Goldberg LLP reminds investors of Galena Biopharma, Inc. ("Galena" or the "Company" (NASDAQ:GALE) that all purchasers of Galena securities between November 6, 2013 and February 14, 2014, inclusive (the "Class Period" , have until May 5, 2014, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit.

Galena Biopharma to Present at the 13th Annual Needham Healthcare Conference
GlobeNewswire - Thu Apr 03, 6:05AM CDT
Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced that Mark J. Ahn, Ph.D., President and Chief Executive Officer will present a corporate update at the 13th Annual Needham Healthcare Conference. The presentation will take place on Tuesday, April 8, 2014 at 8:40 a.m. ET at the Westin Grand Central Hotel in New York, NY.

FDA Panel Grants Market Approval of MannKind Corp.'s Inhalable Insulin
ACCESSWIRE - Wed Apr 02, 8:49AM CDT
On Apr. 1, MannKind Corp. (NASDAQ:MNKD) announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the FDA voted 13 to 1 to recommend that Afrezza, its inhalable insulin, be granted marketing approval by the FDA to improve glycemic control in adults with type 1 diabetes.

Morning Analysis on Top Gainers -- Research on Teva Pharmaceutical Industries, Capstone Turbine, Cigna, and Galena Biopharma
PR Newswire - Tue Apr 01, 8:29AM CDT
The US markets saw a positive sentiment on Monday, March 31, 2014, with the NASDAQ Composite closing at 4,198.99, up 1.04%, the Dow Jones Industrial Average ending the session at 16,457.66, up 0.82% and the S&P 500 edging 0.79% higher to finish the trading session at 1,872.34. The gains were broad based as nine out of 10 sectors ended the session in positive. A number of stocks saw large movements, including Teva Pharmaceutical Industries Ltd (NYSE: TEVA), Capstone Turbine Corp. (NASDAQ: CPST), Cigna Corp. (NYSE: CI) and Galena Biopharma Inc. (NASDAQ: GALE). Free technical research on TEVA, CPST, CI and GALE can be downloaded upon signing up at:

Hagens Berman Reminds Galena Biopharma, Inc. Investors of May 5, 2014, Lead Plaintiff Deadline and Continued Securities Fraud Investigation
Business Wire - Mon Mar 31, 12:37PM CDT
Hagens Berman Sobol Shapiro LLP reminds investors of the May 5, 2014, deadline to file for lead plaintiff in a securities fraud case against Galena Biopharma, Inc. (NASDAQ: GALE) ("Galena" or "the Company" . Investors who bought Galena securities between Nov. 6, 2013, and Feb. 14, 2014 (the "Class Period" , can contact Hagens Berman Partner Reed Kathrein, who is leading the firm's investigation, by calling 510-725-3000, emailing Galena@hbsslaw.com or by visiting http://hb-securities.com/investigations/Galena.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI Echo Study Sharpens a Difficult HFpEF Diagnosis

Updated Category News Views 71

A single echo clip may be doing more useful work than plenty of flashy healthcare AI demos. The November 2026 Journal of Cardiac Failure focus issue puts a hard number on that possibility: pairing an AI read of a routine echocardiogram clip with the H?FPEF clinical score identified 78% of patients with hemodynamically confirmed HFpEF, versus 48% with the score alone. That...

Continue Reading
Grupo Supervielle's Q3 2026: Back to Growth Path

Updated Category News Views 89

Mounting Momentum in Loans and Asset Quality Grupo Supervielle, the Argentine financial player, has been tinkering with its gears to navigate the bumpy roads of 2026. In the third quarter, the company reports a gentle uptick in net loans—up 1.3% sequentially. This was particularly felt in September, with loans increasing 3.7%. Holding Their Own Against the Industry...

Continue Reading
MobileX's $10 Plan Puts Holiday Pressure on Wireless

Updated Category News Views 110

A sixty-dollar commitment is a small bet, but in wireless it can become a loud little nuisance for every carrier charging far more. MobileX has rolled out a Black Friday offer giving new customers 10GB of high-speed data, unlimited talk and text, and six months of service for $60 upfront. That pencils out to $10 a month, before taxes and government surcharges, and it runs...

Continue Reading
BNY's December Conference Slot Merits a Careful Listen

Updated Category News Views 77

A 10:40 a.m. conference appearance can look like wallpaper on a market calendar, but BNY's scheduled December 9 discussion deserves more attention than that. Robin Vince, the chief executive, is set to speak at the Goldman Sachs Financial Services Conference in New York, and the company has plainly warned that the conversation may include forward-looking statements and...

Continue Reading
EUBG Faces Tough Third Quarter Amid Challenges

Updated Category News Views 226

What's Happening with EUBG? Entrepreneur Universe Bright Group, better known in the markets as EUBG, is navigating some choppy waters if their recent financial numbers are anything to go by. You'd think companies boasting a digital-focused strategy would be printing money in today's tech-driven world, but EUBG's third quarter of 2026 has a different story to tell. The...

Continue Reading
CD Rates Offer Stillness as Stocks and Gold Wobble

Updated Category News Views 59

November has delivered the sort of tape that makes a supposedly diversified portfolio feel like a leaky boat. Stocks fell sharply, gold slid to a one-year low after record highs as recently as January, and Treasuries have not provided the dependable ballast many investors expected. When inflation worries and federal-debt concerns shove yields higher, bond prices can drop...

Continue Reading
My Home Delivery's Bold Move in Big & Bulky Sector

Updated Category News Views 112

Redefining Big & Bulky Deliveries with AI Let me tell you, the logistics world isn't for the timid, and My Home Delivery (MHD) is swinging for the fences with their latest tech platform. These folks are rolling out an AI-driven system that promises to turn the bulky goods market on its head. Imagine moving your brand new fridge or that king-size bed across town without...

Continue Reading
LASIK Cost Math Deserves a Careful Second Look Today

Updated Category News Views 66

Thirty years of lens purchases can become a nasty tab Contact-lens spending has a funny way of staying invisible until somebody stacks the receipts into one ugly pile. A new cost-of-vision analysis from the surgeon advisory board of BestLASIKSurgeons.com says the average American contact-lens wearer may spend between $22,500 and $30,000 on corrective eyewear across 30...

Continue Reading
Avelo Tests Loyalty Math With WeSalute Fare Discounts

Updated Category News Views 115

Airline discounts can look like generosity until the load factor starts talking back. Avelo Airlines has joined WeSalute with fare discounts for active-duty military members, veterans, first responders, nurses, medical professionals, public servants, teachers and eligible family members. It is a sensible move for a young carrier built around smaller airports and lower...

Continue Reading
Norris Lake's New Kayak Fleet Propels Tourism Efforts

Updated Category News Views 207

Norris Lake Doubles Down on Water Adventures The winds of change are paddling through Norris Dam State Park as they've launched a new fleet of shiny kayaks, hoping to lure more adventure seekers into the heart of Tennessee. These ain't just boats; they're part of a bigger play by local tourism honchos hungry to pump some adrenaline—and dollars—back into the area. A...

Continue Reading

Top 5 Most Recently Viewed Articles

AWS Unveils New Cloud Infrastructure Region in Mexico

Updated Category News Views 242

AWS Introduces Mexico (Central) Region for Cloud Services Amazon Web Services (AWS), part of Amazon.com, Inc. (NASDAQ: AMZN), has launched its AWS Mexico (Central) Region. This strategic move enhances the options for developers, startups, enterprises, government bodies, educational institutions, and nonprofits seeking to run applications and serve end-users from local AWS...

Continue Reading
Ripple's Investment Boosts Flutterwave's Digital Leap

Updated Category News Views 23

Ripple and Flutterwave Join Forces to Reshape Finance The latest move by Ripple to pump funds into Flutterwave during its Series E funding round is shaking up the digital finance scene in Africa. With this strategic investment, we're witnessing a bold leap toward integrating stablecoins and digital assets into the continent's financial bloodstream. For investors, this...

Continue Reading
Exciting Earnings Announcement from Capital Southwest Corp

Updated Category News Views 37

Capital Southwest Corporation Reveals Earnings Release Schedule Capital Southwest Corporation (NASDAQ: CSWC), an esteemed business development company based in Dallas, is gearing up for the release of its second quarter 2025 financial results. The announcement marks a significant moment for investors keen on following the company's trajectory. Details of the Upcoming...

Continue Reading
Kroger's Ultimate Guide to Crafting Delicious Sandwiches

Updated Category News Views 133

Kroger's Ultimate Guide to Crafting Delicious Sandwiches Crafting a perfect sandwich opens up a world of possibilities, and Kroger is at the forefront of this culinary endeavor. With their latest guide, they provide a wealth of ideas and ingredients, making summer meals not only delicious but also exciting. Imagine sinking your teeth into a variety of stunning...

Continue Reading
NR7 Miner Enhances Mining with Real-Time Optimization Strategy

Updated Category News Views 268

Revolutionizing the Mining Landscape In an exciting development in the world of cryptocurrency, NR7 Miner has launched its Dynamic Chain Optimization System. This innovative upgrade allows users to optimize their mining protocols in real time, significantly increasing their profitability. Embracing Change for Greater Earnings With the launch of this advanced system, NR7...

Continue Reading